Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone214-937-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$453.04 million
Profitability
Miscellaneous
Employees954
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable
Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions
What is Orthofix Medical's stock symbol?
Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
How were Orthofix Medical's earnings last quarter?
Orthofix Medical Inc (NASDAQ:OFIX) posted its earnings results on Monday, August, 5th. The medical device company reported $0.28 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.40 by $0.12. The medical device company had revenue of $115.85 million for the quarter, compared to analyst estimates of $115.17 million. Orthofix Medical had a return on equity of 9.50% and a net margin of 1.75%. The company's quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.42 earnings per share. View Orthofix Medical's Earnings History.
When is Orthofix Medical's next earnings date?
What guidance has Orthofix Medical issued on next quarter's earnings?
Orthofix Medical issued an update on its FY19 earnings guidance on Monday, August, 5th. The company provided earnings per share (EPS) guidance of $1.75-1.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.78. The company issued revenue guidance of $472-477 million, compared to the consensus revenue estimate of $473.70 million.
What price target have analysts set for OFIX?
2 analysts have issued 1 year price objectives for Orthofix Medical's shares. Their forecasts range from $60.00 to $60.00. On average, they expect Orthofix Medical's share price to reach $60.00 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price. View Analyst Price Targets for Orthofix Medical.
What is the consensus analysts' recommendation for Orthofix Medical?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.
Has Orthofix Medical been receiving favorable news coverage?
Press coverage about OFIX stock has been trending positive on Thursday, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthofix Medical earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near term. View News Stories for Orthofix Medical.
Who are some of Orthofix Medical's key competitors?
Some companies that are related to Orthofix Medical include Cantel Medical (CMD), Tandem Diabetes Care (TNDM), NuVasive (NUVA), ICU Medical (ICUI), Nevro (NVRO), Glaukos (GKOS), Merit Medical Systems (MMSI), Irhythm Technologies (IRTC), Cardiovascular Systems (CSII), Atrion (ATRI), Silk Road Medical (SILK), Shockwave Medical (SWAV), AtriCure (ATRC), Cryolife (CRY) and Axonics Modulation Technologies (AXNX).
What other stocks do shareholders of Orthofix Medical own?
Who are Orthofix Medical's key executives?
Orthofix Medical's management team includes the folowing people:
- Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
- Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
- Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
- Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
- Mr. Davide Bianchi, Pres of Global Extremities (Age 54)
Who are Orthofix Medical's major shareholders?
Orthofix Medical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.93%), Vanguard Group Inc. (10.37%), Renaissance Technologies LLC (3.00%), Nuveen Asset Management LLC (2.25%), Victory Capital Management Inc. (2.19%) and Oakview Capital Management L.P. (2.14%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.
Which institutional investors are selling Orthofix Medical stock?
OFIX stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Charles Schwab Investment Management Inc., Invesco Ltd., First Trust Advisors LP, Acadian Asset Management LLC, Russell Investments Group Ltd., BlackRock Inc. and SG Americas Securities LLC. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick and Rice Doug. View Insider Buying and Selling for Orthofix Medical.
Which institutional investors are buying Orthofix Medical stock?
OFIX stock was acquired by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, THB Asset Management, Oakview Capital Management L.P., Marshall Wace LLP, Morgan Stanley, D. E. Shaw & Co. Inc., Vanguard Group Inc. and Pinebridge Investments L.P.. View Insider Buying and Selling for Orthofix Medical.
How do I buy shares of Orthofix Medical?
Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Orthofix Medical's stock price today?
One share of OFIX stock can currently be purchased for approximately $53.58.
How big of a company is Orthofix Medical?
Orthofix Medical has a market capitalization of $1.02 billion and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.
What is Orthofix Medical's official website?
How can I contact Orthofix Medical?
Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]
MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
